Skip to main content
Funded Studies

Using a Systems-based Approach to Study the Molecular Processes Underlying Parkinson’s Disease: The Foundational Data Initiative

Study Rationale: This effort aims to produce foundational data that will provide immediate insight and a resource for understanding the molecular basis of Parkinson disease (PD). The work, conducted in cells derived from participants in the Parkinson Progression Markers Initiative (PPMI) study, will generate data that define the underlying molecular disease networks.

Hypothesis: We hypothesize that systems-based approaches, combined with complex genetics, will provide critical information regarding the molecular processes underlying PD.

Study Design: Cells donated by PPMI volunteers will be cultured and grown into neurons similar to those found in the human brain. A molecular characterization of these cells will provide a map of how the various genetic changes linked to PD interact at the cellular and molecular level to cause disease.

Impact on Diagnosis/Treatment of Parkinson’s disease: This work has the potential to inform diagnosis by defining molecular subtypes of disease. By identifying key networks involved in the disease, this work could lead to viable targets for therapeutic intervention.

Next Steps for Development: The clinical application of these results will rely on the testing of potential therapeutics against identified targets. This system can also be used to test whether an intervention is on target and to detect any unanticipated and likely deleterious off-target side effects.


Researchers

  • Andrew B. Singleton, PhD

    Bethesda, MD United States


  • Peter Heutink, PhD

    Tubingen Germany


  • Kendall Van Keuren-Jensen, PhD

    Phoenix, AZ United States


  • Mark Cookson, PhD

    Bethesda, MD United States


  • David Craig, PhD

    Los Angeles, CA United States


Discover More Grants

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.